Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2024-04-19 M&A Activity
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a 'Report on the Completion of Merger, etc.' (합병등종료보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the completion of an asset acquisition (specifically, the acquisition of convertible bonds of another company, Abion Inc.) by Telcon RF Pharmaceutical. Since this document reports the finalization of a specific corporate transaction (asset acquisition/transfer) rather than a general regulatory announcement or a report publication notice, it falls under the category of M&A Activity (TAR), which covers mergers, acquisitions, and significant asset transfers.
2024-04-19 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement titled '정기주주총회결과' (Annual General Meeting Results) for 텔콘RF제약. It details the outcomes of shareholder votes on financial statements, director appointments, and remuneration limits. This falls directly under the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사). This type of disclosure specifically concerns changes in the board of directors, which falls under the 'Board/Management Information' category.
2024-03-27 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed by 텔콘RF제약. It provides a summary of the audit opinion, key financial data (assets, liabilities, equity, profit/loss), and confirms the receipt of the audit report from the external auditor (동아송강회계법인). While it contains financial data, it is a regulatory disclosure announcement summarizing the audit results rather than the full, multi-page audited financial statements themselves. Under the 'Menu vs Meal' rule, this is a formal regulatory filing announcing the audit outcome. FY 2023
2024-03-19 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Telcon RF Pharmaceutical (주식회사 텔콘알에프제약) for the fiscal year ending December 31, 2023. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an annual report (10-K) which typically includes management discussion and analysis (MD&A) and broader business descriptions, nor is it a short announcement. Therefore, it is classified as an Audit Report. FY 2023
2024-03-19 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Telcon RF Pharmaceutical) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial events. Since it provides specific financial highlights and reasons for the change rather than just announcing the availability of a report, it is classified as an Earnings Release (ER) equivalent in the context of Korean regulatory filings. FY 2023
2024-03-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.